174 related articles for article (PubMed ID: 8564794)
1. Intact parathyroid hormone levels in renal insufficiency.
Fajtova VT; Sayegh MH; Hickey N; Aliabadi P; Lazarus JM; LeBoff MS
Calcif Tissue Int; 1995 Nov; 57(5):329-35. PubMed ID: 8564794
[TBL] [Abstract][Full Text] [Related]
2. Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure.
Kates DM; Sherrard DJ; Andress DL
Am J Kidney Dis; 1997 Dec; 30(6):809-13. PubMed ID: 9398125
[TBL] [Abstract][Full Text] [Related]
3. Secondary hyperparathyroidism in elderly people: combined effect of renal insufficiency and vitamin D deficiency.
Freaney R; McBrinn Y; McKenna MJ
Am J Clin Nutr; 1993 Aug; 58(2):187-91. PubMed ID: 8338046
[TBL] [Abstract][Full Text] [Related]
4. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?
Lomonte C; Antonelli M; Vernaglione L; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Basile C
J Nephrol; 2005; 18(1):96-101. PubMed ID: 15772930
[TBL] [Abstract][Full Text] [Related]
5. Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial).
Ritz E; Küster S; Schmidt-Gayk H; Stein G; Scholz C; Kraatz G; Heidland A
Nephrol Dial Transplant; 1995 Dec; 10(12):2228-34. PubMed ID: 8808216
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Lack of influence of recombinant human erythropoietin on parathyroid function in hemodialysis patients with secondary hyperparathyroidism.
Lai YH; Tsai JC; Chen HC; Guh JY; Hwang SJ; Tsai JH
Nephron; 1995; 70(2):223-8. PubMed ID: 7566308
[TBL] [Abstract][Full Text] [Related]
8. Impact of renal failure on metabolic bone parameters in a vitamin D-deficient patient cohort.
Reinhardt W; Dolff S; John P; Kribben A; Witzke O
Clin Nephrol; 2011 May; 75(5):403-9. PubMed ID: 21543019
[TBL] [Abstract][Full Text] [Related]
9. Calcium-dependent release of N-terminal fragments and intact immunoreactive parathyroid hormone by human pathological parathyroid tissue in vitro.
el-Hajj Fuleihan G; Chen CJ; Rivkees SA; Marynick SP; Stock J; Pallotta JA; Brown EM
J Clin Endocrinol Metab; 1989 Oct; 69(4):860-7. PubMed ID: 2778039
[TBL] [Abstract][Full Text] [Related]
10. Lack of relationship between parathyroid hormone and 1,25-dihydroxyvitamin D in chronic renal failure.
Rudnicki M; McNair P; Transbøl I; Nielsen B
Nephron; 1991; 58(2):144-9. PubMed ID: 1865969
[TBL] [Abstract][Full Text] [Related]
11. Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism.
Reichel H; Deibert B; Schmidt-Gayk H; Ritz E
Nephrol Dial Transplant; 1991; 6(3):162-9. PubMed ID: 1866044
[TBL] [Abstract][Full Text] [Related]
12. Long-term evolution of the mineral metabolism after renal transplantation: a prospective, single-center cohort study.
Van de Cauter J; Sennesael J; Haentjens P
Transplant Proc; 2011 Nov; 43(9):3470-5. PubMed ID: 22099822
[TBL] [Abstract][Full Text] [Related]
13. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
O'Flaherty D; Sankaralingam A; Scully P; Manghat P; Goldsmith D; Hampson G
Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly.
Souberbielle JC; Cormier C; Kindermans C; Gao P; Cantor T; Forette F; Baulieu EE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3086-90. PubMed ID: 11443171
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
[TBL] [Abstract][Full Text] [Related]
16. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
Borrego Utiel FJ; Bravo Soto JA; Merino Pérez MJ; González Carmelo I; López Jiménez V; García Álvarez T; Acosta Martínez Y; Mazuecos Blanca MA
Nefrologia; 2015; 35(4):363-73. PubMed ID: 26306956
[TBL] [Abstract][Full Text] [Related]
17. Values of intact serum parathyroid hormone in different stages of renal insufficiency.
Hellman P; Backman U; Danielson BG; Akerström G; Rastad J; Wide L; Ljunghall S
Scand J Urol Nephrol; 1991; 25(3):227-32. PubMed ID: 1947852
[TBL] [Abstract][Full Text] [Related]
18. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
[TBL] [Abstract][Full Text] [Related]
19. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone and large related C-terminal fragments increase at different rates with worsening of renal function in chronic kidney disease patients. A possible indicator of bone turnover status?
Donadio C; Ardini M; Lucchesi A; Donadio E; Cantor T
Clin Nephrol; 2007 Mar; 67(3):131-9. PubMed ID: 17390737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
